Scleroderma News - Web sanofi will be the first company to join conquest, a new platform trial launched by the scleroderma research. Web systemic sclerosis, also termed scleroderma, is a multisystem connective tissue disease involving. Web in their new study published in jci insight, researchers found that tofacitinib was well tolerated among patients with. Web having scleroderma increases the risk of developing diseases affecting blood vessels of the brain or heart, known as. Web as an innovator in scleroderma research, the srf is uniquely qualified to provide those living with scleroderma, the medical.
Web systemic sclerosis, also termed scleroderma, is a multisystem connective tissue disease involving. Web in their new study published in jci insight, researchers found that tofacitinib was well tolerated among patients with. Web as an innovator in scleroderma research, the srf is uniquely qualified to provide those living with scleroderma, the medical. Web having scleroderma increases the risk of developing diseases affecting blood vessels of the brain or heart, known as. Web sanofi will be the first company to join conquest, a new platform trial launched by the scleroderma research.